Funksjonell genomforskning (FUGE)
3treff
| Periode | Prosjekttittel | Prosjektleder |
|---|---|---|
| 2008 - 2012 | Development of high througput affinity protemics to search for drug targets in cancer....networks that regulate cell division and turnover. Lund-Johansen (RH-Gaustad Institute of Immunology) has developed...protemics to search for drug targets in cancer. Fridtjof Lund-Johansen 187606 Medisinske fag Basale med./odont./vet... | Fridtjof Lund-Johansen |
| 2008 - 2012 | National-wide service and competence from the Rikshospitalet-Radiumhospitalet Proteomics Core Facility in a Norwegian proteomics consortium...result in a continuous research-driven development of new techniques at the RR-PCF. In collaborations with Fridtjof Lund -Johansen and with Clive D'Santos at PROBE/Bergen, we will focus on establishing methods for high-throughput screening... | Gustavo De Souza |
| 2007 - 2010 | Development of high througput affinity protemics to search for drug targets in cancer. (plattform bevilgning)Development of high througput affinity protemics to search for drug targets in cancer. (plattform bevilgning) Fridtjof Lund-Johansen 187188 Teknologi Bioteknologi Bioteknologi Norge OSLO OSLO Funksjonell genomforskn.i Norg | Fridtjof Lund-Johansen |
